ALNY Data

$ALNY | Alnylam Pharmaceuticals, Inc. Social Data » 1) Follower Data, 2) Sentiment Data, 3) Posts Data | Data Mined from SpeculatingStocks Pulse Social Network

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Followers: 1

'Buys': 0 | 'Sells': 0

'Buys' Yesterday: 0 | 'Sells' Yesterday: 0

B/S Rating Today: 0 | B/S Rating All-Time: 0

Avg. Number of Pulses a Day: 0.75 | Total Number of Pulses All-Time: 1259

Total Number of Pulses Yesterday: 0

More: $ALNY (Alnylam Pharmaceuticals, Inc.) Stream, Posts, and Sentiment Page

CLICK for All ALNY POSTS from the ALNY Pulse Symbol Stream

ALNY | Alnylam Pharmaceuticals, Inc. Financial Data » 1) Annual Financials, 2) Quarterly Financials, and 3) Key Metrics

Market Cap: $8.085B

Income Statement:

Revenue: $74.91M

Net Income: $(761.5M)

Cash Flow Statement:

Change in Cash / Cash Equiv.: $(224.2M)

Balance Sheet:

Cash / Cash Equiv. + ST Investments: $1.08B

Short Term Debt: None

Long Term Debt: $30M

Total Current Assets: $1.2B

Total Current Liabilities: $179.49M

Total Assets: $1.57B

Total Liabilities: $272.84M

Stockholder Equity: $1.3B

Annual ALNY Income Statement

Annual ALNY Cash Flow Statement

Annual ALNY Balance Sheet

Income Statement:

Revenue: $33.29M

Net Income: $(181.92M)

Cash Flow Statement:

Change in Cash / Cash Equiv.: $305.07M

Balance Sheet:

Cash / Cash Equiv. + ST Investments: $1.24B

Short Term Debt: $16.98M

Long Term Debt: $30M

Total Current Assets: $1.39B

Total Current Liabilities: $149.16M

Total Assets: $2.01B

Total Liabilities: $467.01M

Stockholder Equity: $1.55B

Quarterly ALNY Income Statement

Quarterly ALNY Cash Flow Statement

Quarterly ALNY Balance Sheet

Market Cap: $8.085B

Trailing PE: N/A

Price to Sales (Based on Most Recent Annual Revenue): 107.93

Price to Book (Based on Most Recent Quarter Stockholder Equity): 5.22

Beta: 2.36

More Key ALNY Financial Metrics

Please Give Tips to Others about Insight Gained from ALNY Financials

Share: 1) Share Your Opinion of ALNY, 2) Place a 'Buy' or 'Sell' Sentiment on ALNY

ALNY | Alnylam Pharmaceuticals, Inc. Research » 1) Share Data, 2) Short Data, 3) Insider Data, and 4) Corporate Data

Outstanding Shares: 106.54M

Shares in Float: 94.74M

Percent of Float Short: 5.25%

Shares Short: 4.97M

Shares Held by Insiders: N/A

Shares Held by Institutions: N/A

More ALNY Insider Data

CEO: Mr. Barry E. Greene

Employees: 1,065

More Corporate Data on ALNY

Please Give Tips to Others about Insight Gained from ALNY Research

Share: 1) Share Your Opinion of ALNY, 2) Place a 'Buy' or 'Sell' Sentiment on ALNY

ALNY | Alnylam Pharmaceuticals, Inc. Charts » 1) 10-Year, 2) 5-Year, 3) 1-Year, 4) 6-Month, 5) 3-Month, 6) 1-Month, 7) 1-Day

↻   Update ALNY Symbol Stream